Filter
487
Filtered Results: 487
Text search:
University
of
Melbourne
Featured
Recommendations
73
New Publications
83
Language
Document type
No document type
212
Guidelines
91
Studies & Reports
90
Manuals
52
Training Material
25
Strategic & Response Plan
11
Fact sheets
4
Resource Platforms
1
Infographics
1
Countries / Regions
Global
20
India
11
Kenya
7
Western and Central Europe
7
Brazil
7
Cambodia
6
Asia
6
Germany
5
Uganda
5
Nepal
4
Nigeria
4
Mozambique
4
Western Pacific Region
4
Vietnam
4
Ethiopia
4
Myanmar / Burma
4
Ukraine
3
Philippines
3
Tanzania
3
Jordan
3
Eastern Europe
3
Sri Lanka
3
Indonesia
3
Rwanda
2
Senegal
2
Malawi
2
Africa
2
Guinea-Bissau
2
Latin America and the Carribbean
2
Congo, Democratic Republic of
2
South–East Asia Region
2
Eastern Europe and Central Asia
2
United Kingdom
2
Spain
2
Bangladesh
2
South Africa
2
Angola
2
Zambia
2
South Sudan
2
Somalia
2
Liberia
2
North Macedonia
1
Tajikistan
1
Timor Leste/ East Timor
1
Lesotho
1
Turkey
1
Ghana
1
Sierra Leone
1
Kazakhstan
1
Syria
1
Iran
1
Canada
1
Laos
1
Estonia
1
Kyrgyzstan
1
Burkina Faso
1
Afghanistan
1
Qatar
1
Guinea
1
Italy
1
Armenia
1
USA
1
North America
1
Belgium
1
France
1
Portugal
1
Belarus
1
East and Southern Africa
1
Lebanon
1
Papua New Guinea
1
Russia
1
Romania
1
Georgia
1
Central African Republic
1
Iraq
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
75
Clinical Guidelines
65
Women & Child Health
33
Public Health
25
Key Resources
19
Pharmacy & Technologies
7
Capacity Building
5
Toolboxes
Mental Health
123
COVID-19
53
Disability
36
HIV
33
TB
28
NTDs
23
Planetary Health
22
NCDs
16
Global Health Education
15
Caregiver
13
Refugee
12
AMR
9
Rapid Response
8
Natural Hazards
7
Ebola & Marburg
6
Pharmacy
5
Polio
5
Malaria
4
2.0 Rapid Response
4
Conflict
4
Zika
4
Cholera
1
Health Financing Toolbox
1
Cryptococcal disease is one of the most common opportunistic infections among people living with advanced HIV disease and is a major contributor to severe illness, morbidity, and mortality, particularly in sub-Saharan Africa.
These guidelines update the recommendations that were first released i...
WHO guideline on balanced national controlled medicines policies to ensure medical access and safety
Access to medicines is essential for attainment of universal health coverage, which is central to achievement of the health-related Sustainable Development Goals. Controlled medicines include those such as opioids, benzodiazepines, barbiturates, amphetamines and others with identified or emergent cl...
Guidance for clinical case management of thrombosis syndrome with thrombocytopenia (TTS) following vaccination to prevent coronavirus disease (COVID-19)
Interim guidance 19 July 2021
The World Health Organization (WHO) convened a meeting of the Technical Advisory Group on Buruli ulcer at its headquarters in Geneva, Switzerland on 25 to 27 March 2019
An estimated 1.3 billion people – or 16% of global population worldwide – experience a significant disability today. Persons with disabilities have the right to the highest attainable standard of health as those without disabilities. However, the WHO Global report on health equity for persons w...
Including a Tool to Assess the Adolescent Health and Development Component in Pre-Service Education of Health-Care Providers
This curricula guide builds on several existing products of WHO and partners, aimed at supporting countries in their effort to address the first objective of the GAP-AMR (to improve awareness and understanding of AMR). It is targeted specifically at health educators and policy planners, and applies ...
Ensuring mental health and well-being has become a worldwide imperative and an important target
of the Sustainable Development Goals.
But in all countries around the world, our response has been woefully insufficient, and we have made
little progress to advance mental health as a fundamental huma...
The Polio Transition1
Monitoring and Evaluation (M&E) Framework was designed to monitor progress towards achieving the strategic and operational outcomes of the post-2023 Strategic Action Plan on Polio Transition (2018– 2023), as outlined in the Global Vision to use polio investments to build st...
This revised and fully updated edition of the
International technical guidance on sexuality education
benefits from a new review of the current evidence, and reaffirms the position of sexuality education within a framework of human rights and gender equality. It promotes structured learning about...
Person-centred recovery planning for mental health and well-being: self-help tool: WHO QualityRights
Ensuring mental health and well-being has become a worldwide imperative and an important target of the Sustainable Development Goals. But in all countries around the world, our response has been woefully insufficient, and we have made
little progress to advance mental health as a fundamental human ...
Overwhelming evidence shows that a range of health concerns—mental illness, substance dependence, HIV/AIDS, and noncommunicable diseases—affect prisoners disproportionately. But, while incarceration poses risks to health—including inadequate nutrition and exposure to violence—prisons also pr...
The Asia-Pacific Community Mental Health Development (APCMHD) project has been established in 2005 to explore diverse leading models or approaches to community mental health service delivery in the Asia-Pacific region. The objective is to illustrate and promote best practice in mental health care in...
Latent Tuberculosis Infection : Updated and consolidated guidelines for programmatic management
recommended
The consolidated guidelines are expected to provide the basis and rationale for the development of national guidelines for LTBI management, adapted to the national and local epidemiology of TB, the availability of resources, the health infrastructure and other national and local determinants. The gu...
Scabies is a global health concern disproportionately affecting vulnerable populations such as refugees and asylum seekers. Greece is a main point of entry in Europe for refugees, but epidemiological data on scabies in this population are scarce. We aimed to describe the epidemiology of scabies, inc...
The meningitis road map has been designated as a flagship global strategy of the WHO’s Thirteenth General Programme of Work, 2019–2023 and is an essential component in achieving universal health coverage.
The road map will reinforce and combine with wider initiatives, such as those aimed at s...
WHO guidelines on the pharmacological treatment of persisting pain in children with medical illnesses
WHO published guidance for clinicians and health care decision-makers on the use of corticosteroids in patients with COVID-19.
We recommend systemic corticosteroids for the treatment of patients with severe and critical COVID-19. We suggest not to use corticosteroids in the treatment of patients ...
WHO Living guideline: Drugs to prevent COVID-19
recommended
Interim guidance 2 march 2021
Current use of drugs to prevent COVID-19 is variable, reflecting large-scale uncertainty. Numerous randomized trials of many different drugs are underway to inform practice. This first version of the Drugs to prevent COVID-19: A WHO living guideline contains new inform...
Air pollution is a major environmental risk factor and contributor to chronic, noncommunicable diseases (NCDs). However, most public health approaches to NCD prevention focus on behavioural and biomedical risk factors, rather than environmental risk factors such as air pollution. This article discus...
